You may turn out to be right @long_haul. But that seems to put no value on the rest of the generics pipeline and the possibility of Acrux developing a sustainable and highly cashflow generative business, going forward.
That seems to me to be throwing away a lot of value.
To me, the risk/reward curve still looks heavily skewed to the up side.
ACR Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)